Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NDRA

ENDRA Life Sciences Inc

May 27 • 04:00PM ET

5.36

+0.16 3.08 %

Healthcare • Diagnostics & Research • USA • Nano • NASD

Peers: ADVB BIAF ISPC MBAI NOTV XWEL MDXH PRPO QUCY XGN

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.15	Insider Own	48.00%	Shs Outstand	1.24M	Perf Week	-4.11%
Market Cap	6.81M	Forward P/E	-	EPS next Y	-4.00	Insider Trans	0.00%	Shs Float	0.66M	Perf Month	11.20%
Enterprise Value	6.91M	PEG	-	EPS next Q	-1.14	Inst Own	7.06%	Short Float	4.94%	Perf Quarter	40.68%
Income	-7.30M	P/S	-	EPS this Y	47.93%	Inst Trans	2.60%	Short Ratio	0.90	Perf Half Y	24.65%
Sales	0.00M	P/B	3.72	EPS next Y	13.98%	ROA	-220.99%	Short Interest	0.03M	Perf YTD	18.32%
Book/sh	1.44	P/C	18.92	EPS next 5Y	-	ROE	-412.60%	52W High	11.96 -55.18%	Perf Year	69.09%
Cash/sh	0.28	P/FCF	-	EPS past 3/5Y	89.62% 79.05%	ROIC	-345.41%	52W Low	2.91 83.88%	Perf 3Y	-99.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.91% 8.02%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	98.32%	Oper. Margin	-	ATR (14)	0.45	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.64	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.97	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.64	EPS Q/Q	41.18%	SMA20	2.63%	Beta	-0.06	Target Price	27.00
Payout	-	Debt/Eq	0.26	Sales Q/Q	-	SMA50	9.61%	Rel Volume	0.81	Prev Close	5.20
Employees	11	LT Debt/Eq	0.18	Earnings	May 18 BMO	SMA200	10.16%	Avg Volume	36.15K	Price	5.36
IPO	Jun 30, 2017	Option/Short	No / Yes	EPS/Sales Surpr.	11.38% -	Trades		Volume	29,954	Change	3.08%

May-18-26 08:00AM	ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update (Business Wire) +7.13%
May-14-26 08:00AM	ENDRA Life Sciences Reports Multi-Site Validation of TAEUS Liver Device Demonstrating MRI-like Accuracy and Reproducibility (Business Wire)
Mar-31-26 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (Business Wire)
Mar-25-26 08:00AM	ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value (Business Wire) +8.38%
Mar-03-26 10:15AM	NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision (Zacks)
08:00AM	Loading…
Feb-26-26 08:00AM	ENDRAs TAEUS Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care (Business Wire)
Dec-04-25 08:00AM	ENDRA's TAEUS Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use (Business Wire) -7.67%
Nov-20-25 08:00AM	ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker (Business Wire) -15.19%
Nov-17-25 08:00AM	ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results (Business Wire) -7.46%
Nov-14-25 09:25AM	Endra Life Sciences commences staking of HYPE digital asset holdings (TipRanks)
Oct-23-25 08:00AM	ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings (Business Wire) -5.88%
Oct-16-25 08:57AM	Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition (Zacks) -5.53%
Oct-13-25 08:14AM	Pulse Biosciences Unveils Promising First-in-Human Data for nPulse (Zacks) +25.31%
08:00AM	ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca (Business Wire)
Aug-14-25 04:05PM	ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results (Business Wire) +9.46%
08:00AM	Loading…
Jun-16-25 08:00AM	ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard (Business Wire)
May-15-25 04:05PM	ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results (Business Wire)
Mar-31-25 08:05AM	ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies (Business Wire)
08:00AM	ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update (Business Wire)
Jan-28-25 12:00PM	What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock (Zacks)
Nov-22-24 08:00AM	ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire)
Nov-15-24 09:24AM	ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -14.18%
Nov-12-24 08:00AM	Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting 2024 (Business Wire)
Nov-06-24 08:00AM	ENDRA Life Sciences Further Strengthens TAEUS Platform Intellectual Property with Issuance of 17th European Patent (Business Wire) -14.84%
Oct-22-24 08:00AM	ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany (Business Wire) +89.19%
Aug-28-24 04:17PM	ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements (Business Wire) -19.56%
Aug-22-24 04:14PM	ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -10.99%
Aug-16-24 08:00AM	ENDRA Life Sciences Announces Reverse Stock Split (Business Wire) -22.50%
Aug-13-24 04:05PM	ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 (Business Wire)
08:00AM	ENDRA Life Sciences Announces Leadership Changes (Business Wire)
08:00AM	Loading…
Aug-07-24 08:00AM	ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 (Business Wire)
Jun-17-24 08:11AM	Why Is ENDRA Life Sciences (NDRA) Stock Up 36% Today? (InvestorPlace) +34.17%
07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-05-24 07:35AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +63.41%
Jun-04-24 09:21AM	ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering (Business Wire) -60.83%
May-20-24 08:00AM	ENDRA Provides Update Following In-person Meeting with FDA (Business Wire)
May-15-24 03:10AM	ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-14-24 04:05PM	ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update (Business Wire)
May-07-24 08:00AM	ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024 (Business Wire) -6.41%
May-02-24 08:00AM	ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents (Business Wire) +15.48%
Apr-01-24 09:59AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.50%
Mar-29-24 06:21AM	Q4 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	NDRA Stock Earnings: ENDRA Life Sciences Beats EPS for Q4 2023 (InvestorPlace) -29.29% -30.50%
04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire)
Mar-21-24 08:00AM	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 (Business Wire) -8.76%
Feb-27-24 08:00AM	ENDRA Life Sciences Installs First TAEUS System in the UK (Business Wire)
Feb-21-24 08:00AM	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences TAEUS System (Business Wire)
Feb-14-24 08:30AM	ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe (Business Wire)
Nov-29-23 08:00AM	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS System Technology (Business Wire)
Nov-27-23 08:00AM	ENDRA Life Sciences to Participate in The Benchmark Companys 12th Annual Discovery One-on-One Investor Conference (Business Wire)
Nov-15-23 01:23PM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:05PM	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Nov-08-23 08:00AM	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents (Business Wire)
Nov-07-23 04:05PM	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023 (Business Wire)
Nov-06-23 08:00AM	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLDs The Liver Meeting 2023 (Business Wire)
Sep-07-23 08:00AM	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023 (Business Wire)
Aug-30-23 08:00AM	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA (Business Wire) +6.31%
Aug-23-23 08:00AM	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents (Business Wire)
Aug-20-23 11:20AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-15-23 06:49AM	Q2 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -8.37%
Aug-14-23 04:05PM	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update (Business Wire)
01:30PM	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA (Business Wire)
Aug-01-23 08:00AM	ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023 (Business Wire)
Jul-12-23 05:15PM	Domino's Pizza teams up with Uber for food delivery partnership (Yahoo Finance Video)
03:27PM	Stocks to Watch Wednesday: Domino's, Coty, Activision, Lucid (The Wall Street Journal)
02:42PM	Analyst Report: Domino's Pizza, Inc. (Morningstar Research)
02:01PM	Domino's stock jumps on partnership with Uber Eats (Yahoo Finance)
12:31PM	Dominos Pizza Is Todays Hottest Stock (The Wall Street Journal)
10:30AM	Domino's Pizza stock jumps on delivery partnership with Uber (Yahoo Finance Video)
09:42AM	Dominos Pizza Is This Mornings Hottest Stock (The Wall Street Journal)
07:05AM	Domino's® Introduces a New Way to Order Using Uber Eats Marketplace (PR Newswire)
Jul-06-23 04:45PM	ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023 (Business Wire)
Jun-07-23 08:00AM	Study Highlighting ENDRA Life Sciences TAEUS Technology to be Presented at EASL International Liver Congress 2023 (Business Wire) +5.33%
May-15-23 04:05PM	ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update (Business Wire) -8.57%
May-04-23 08:00AM	ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023 (Business Wire) +8.70%
May-02-23 04:01PM	ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Securities (Business Wire) +17.24% -5.29%
Apr-28-23 08:00AM	ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering (Business Wire) +24.03%
Mar-17-23 05:00AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.00%
Mar-15-23 10:32AM	Q4 2022 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-23 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Mar-07-23 04:05PM	ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023 (Business Wire)
Dec-08-22 09:55AM	Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher (Zacks) +6.79%
Dec-05-22 08:00AM	ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split (Business Wire) -12.10%
Nov-14-22 04:05PM	ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -10.22%
Nov-09-22 08:00AM	ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022 (Business Wire) -7.51%
Oct-25-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents (Business Wire)
Oct-04-22 08:00AM	ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference (Business Wire)
Sep-29-22 04:05PM	ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks (Business Wire)
Sep-06-22 08:00AM	ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences (Business Wire)
Aug-24-22 08:40AM	ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System (Business Wire) +11.62%
Aug-15-22 04:30PM	Edited Transcript of NDRA.OQ earnings conference call or presentation 15-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents) -7.87%
04:05PM	ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-08-22 10:16AM	Here's Why ENDRA Life Sciences (NASDAQ:NDRA) Must Use Its Cash Wisely (Simply Wall St.)
Aug-04-22 08:00AM	ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-02-22 08:00AM	ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices (Business Wire)
Aug-01-22 08:00AM	ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference (Business Wire) +14.63%
Jul-11-22 08:00AM	ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System (Business Wire)
Jun-28-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent (Business Wire) +7.11%
Jun-08-22 08:00AM	ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference (Business Wire) +6.97%
May-25-22 08:00AM	ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent (Business Wire)

ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

CEO & ChairmanMr. Alexander Y. Tokman

CFO & SecretaryMr. Richard Jacroux

Co-FounderDr. Jonathan Behr Ph.D.

Head of OperationsMr. Scott Sober

Head of Regulatory & Clinical AffairsMr. Ziad Rouag J.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NDRA

ENDRA Life Sciences Inc

Upgrade your Finviz experience